George Faurot

Senior Partner and Chief Operating Officer

George F. Faurot oversees the planning and execution of Phase 1–3 clinical development programs for biotechnology and pharmaceutical sponsors. He has extensive experience in clinical operations and has supported several successful NDA approvals. He began his career at Syntex Research in preclinical toxicology and later transitioned into clinical research roles at Syntex, Matrix Pharmaceutical, and Oculex Pharmaceuticals. Mr. Faurot holds a BS in Environmental Toxicology from the University of California, Davis.